The Jehovah's Witness obstetric patient - a literature review.
Clicks: 256
ID: 77346
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
69.0
/100
250 views
202 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The patient's right to refuse blood transfusion must be honoured in case of its clear expression. Some special pharmacologic and/or surgical procedures can be useful in a Jehovah Witness (JW) parturient. In case of excess blood loss the maintenance of peripheral tissue oxygenation is crucial. Only a few hospitals have equipment for blood salvage, and alternative oxygen carriers have potentially lethal side effects. Findings suggest that obstetric facilities should develop special algo-rithms of management in the case of the JW obstetric patient, with written declaration of which elements of blood are not acceptable for the patient, early diagnosis and intensive treatment of anaemia in pregnancy, administration of antifibrinolytic agents before surgery, use of electric surgical tools to restore haemostasis, early detection and aggressive treatment of excessive blood loss and, last but not least, close cooperation between obstetricians and anaesthesiologists, including sharing the information about the patient's refusal of blood transfusion.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (151 words).
Try re-searching for a better abstract.
| Reference Key |
rajewska2019theanaesthesiology
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Rajewska, Aleksandra;Mikołajek-Bedner, Wioletta;Sokołowska, Małgorzata;Lebdowicz, Joanna;Kwiatkowski, Sebastian;Torbè, Andrzej; |
| Journal | anaesthesiology intensive therapy |
| Year | 2019 |
| DOI |
39236
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.